Related Experiment Video
Updated: Apr 10, 2026
07:29
HPLC Coupled with Chemical Fingerprinting for Multi-Pattern Recognition for Identifying the Authenticity of Clematidis Armandii Caulis
Published on: November 11, 2022
2.6K
[Counterfeit and Falsified Drugs: an Overview]
Corine Taverriti-Fortier1, Elise Pape1, Julien Scala-Bertola2
1CHU Nancy, Laboratoire de Pharmacologie Clinique et Toxicologie, Nancy, France.
Therapie
|June 14, 2015
Summary
Fake medicines pose a significant economic threat and public health risk. Current penalties focus on intellectual property, neglecting the broader safety concerns for patients worldwide.
Area of Science:
- Pharmaceutical Science
- Public Health
- Regulatory Affairs
Context:
- The global traffic of falsified medicines generates over 55 billion euros annually.
- Disparities exist, with falsified drug rates from 1% in regulated markets to 60% in developing nations.
- Existing penalties for counterfeit drugs primarily address intellectual property rights, not public health safety concerns.
Purpose:
- To highlight the dual economic and safety threats posed by fake medicines.
- To underscore the inadequacy of current legal responses to the falsified drug trade.
- To advocate for comprehensive strategies addressing the falsified drug problem.
Summary:
- Falsified medicines present a substantial economic threat to the pharmaceutical industry and a critical safety concern for patients.
- The global market for counterfeit drugs is vast, with significant regional variations in prevalence.
- Current measures to combat this traffic encompass legislation, cooperation, enforcement, technology, and communication, emphasizing public awareness of risks associated with non-legal drug sources.
Impact:
- Increased awareness among health professionals and the public regarding the dangers of counterfeit pharmaceuticals.
- Potential for revised legal frameworks and enforcement strategies to better protect public health.
- Reduced economic losses for the pharmaceutical sector and improved patient safety outcomes.
Related Concept Videos
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
228
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
228
01:02Prescription, Nonprescription and Orphan Drugs
1.4K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K
01:28Drug Products: Biologics, Biosimilars and Interchangeables
357
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
357
01:25Drug Regulation
3.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.3K
01:25Drug Classes and Categories
3.4K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
3.4K
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
221
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
221